In vitro susceptibility of Mycobacterium tuberculosis to fusidic acid

Clin Microbiol Infect. 2001 Dec;7(12):700-2. doi: 10.1046/j.1469-0691.2001.00341.x.

Abstract

The aim of this study was to determine the in vitro susceptibility of 170 clinical isolates of Mycobacterium tuberculosis to fusidic acid using a proportion dilution method. Nineteen isolates were resistant to at least one first-line anti-tuberculosis drug. A total of 1.8% of the isolates were resistant to fusidic acid. Fusidic acid should be evaluated clinically as a potential supplementary drug for the treatment of infections due to multidrug-resistant strains of M. tuberculosis.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Antitubercular Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Resistance, Bacterial
  • Fusidic Acid / pharmacology*
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects*

Substances

  • Anti-Bacterial Agents
  • Antitubercular Agents
  • Fusidic Acid